milwaukee glp-1 medication GLP-1s Bariatric Fusion GLP Medicare expands access to GLP-1

SURPASS-CVOT: head-to-head cardiovascular data The SURPASS-CVOT trial compared tirzepatide directly against dulaglutide in patients with type 2 diabetes and established cardiovascular disease

One side of my face has already disappeared

Throw away after one use, even if there is still medicine left inside

The current boxed warning for thyroid C-cell tumors based on rodent data, and warnings for acute pancreatitis, gallbladder disease, acute kidney injury related to volume depletion, severe gastrointestinal reactions, diabetic retinopathy complications in patients with type 2 diabetes, and other concerns

Biotin: the overhyped supplement Biotin is the most marketed hair supplement, and the evidence for it is weak unless you are actually biotin deficient